Invivoscribe Announces the PrepQuant™ System, an Integrated Sample Preparation Platform that Standardizes and Streamlines Pre-Analytical Workflows

SAN DIEGO — Invivoscribe^®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, today announced the launch of the PrepQuant^™ System, a novel sample preparation platform that integrates nucleic acid extraction, concentration, and quantification with a single automated instrument. This innovative system is designed to standardize sample preparation and simplify pre-analytical workflows to reduce costs and eliminate a primary source of inconsistency in molecular testing. Read More